Advertisement
Home Tags Screening

Tag: Screening

Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC

Less Than One in 20 Eligible Adults Receives Lung Cancer Screening

0

Lung cancer screening at the state level does not correlate with lung cancer burden

Medicaid Expansion Tied to Increased Detection of Early Cancers

0

Three years after expansion, a decrease in late-stage cancers was also detectable

HealthDay Reports: Brazil

FDA Approves First Rapid COVID-19 Test for Home Use

0

Simple nasal swab test requires prescription; people younger than 14 cannot perform the test on themselves

Okada Test Article

Routine COVID-19 Testing Improves Safety of Elective Surgery

0

Benefits of nasal swab testing seen in high-transmission areas and before major surgery

Positive BRCA Test Results Down From 2008 to 2018

0

Socioeconomic and regional disparities persist in the use of BRCA testing

USPSTF Finds Evidence Lacking for Child HTN Screening

0

I statement based on lack of studies examining benefits and harms of screening, impact of treatment on outcomes in adulthood

'Watch and Wait' Feasible for Some Rectal Cancer Patients

Higher Health Literacy Linked to Odds of PSA Screening

0

However, patients with higher health literacy less likely to undergo PSA screening in the presence of shared decision-making

Considerable Decreases Seen in Health Care Use During COVID-19

0

Reductions reported in colonoscopies, mammograms, child vaccines, in-person office visits; telemedicine service use up in March, April 2020

The U.S. Preventive Services Task Force (USPSTF) concludes that there is a substantial net benefit for screening adults age 50 to 75 years for colorectal cancer and moderate net benefit for adults ages 45 to 49 years. These findings form the basis of a draft recommendation statement published online Oct. 27 by the USPSTF.

USPSTF Issues Draft Recommendation for CRC Screening

0
Benefit substantial for adults aged 50 to 75 years; benefit moderate for adults aged 45 to 49 years
Interval breast cancers account for one-fourth of breast cancers detected in routinely screened women

Interval Breast Cancers Tied to Worse Outcomes

0
Risk for breast cancer death more than threefold higher for interval versus screen-detected cancer